Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
115 participants
INTERVENTIONAL
2025-02-15
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep and Stress Study
NCT07315516
The Effect of Adaptogen Elixir on Sleep Improvement
NCT06279312
Functional Assessment of Ashwagandaha Root Extract During Weight Loss
NCT03112824
Short-Term Rhodiola Rosea for Anaerobic Performance and Cognitive Function in Resistance-Trained Adults
NCT07225413
Dietary Supplement With Magnesium, Vitamins, Rhodiola and L-theanine Stressed Subjects: Randomized Study Versus Placebo (MAGRITTE)
NCT04391452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AM active, PM active
All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin))
Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin.
AM active, PM placebo
AM Active Supplement Combination (Ashwagandha and Rhodiola rosea)
Ashwagandha and Rhodiola rosea
AM placebo, PM active
PM Active Supplement Combination (Magnesium threonate, L-theanine, and apigenin)
Magnesium threonate, L-theanine, and apigenin.
AM placebo, PM placebo
AM and PM Placebo
Placebo AM and PM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin))
Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin.
AM Active Supplement Combination (Ashwagandha and Rhodiola rosea)
Ashwagandha and Rhodiola rosea
PM Active Supplement Combination (Magnesium threonate, L-theanine, and apigenin)
Magnesium threonate, L-theanine, and apigenin.
AM and PM Placebo
Placebo AM and PM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to give voluntary consent, be able to understand and read the questionnaires, carry out all study-related procedures, communicate effectively with the study staff, and agree to allow any study-related evaluations.
* Participant is physically active: participating in resistance and/or endurance exercise ≥150 min/wk for ≥6 mo.
* Participant will be asked about dietary supplementation use within the past 6 months.
If participant began taking a supplement within the past month, participant will be asked to discontinue supplement use followed by a 2-week washout prior to participation.In all other cases, supplement use will be asked to be maintained throughout the study.
• The participant has an apple device with iOS 16 or greater software.
Exclusion Criteria
* Participants currently taking any of the investigational products will be excluded.
* Female participants who are lactating, pregnant, or planning to become pregnant during the study.
* Diagnosed with any sleep-related or stress-related disorders.
* Currently taking medication to manage sleep or cortisol levels.
* Participants with controlled or uncontrolled hypertension including stage 1 hypertension (systolic blood pressure ≥129 mmHg and diastolic blood pressure ≥89 mmHg).
* Any other condition or abnormality that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Momentous
UNKNOWN
University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shawn M. Arent
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Carolina Sport Science Lab
Columbia, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00141237
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.